Price Alert

Baird Medical Investment ... (BDMD)

NASDAQ: BDMD · Real-Time Price · USD

2.03

-0.10 (-4.69%)

At close: Aug 19, 2025, 1:52 PM

Baird Medical Investment Statistics

Share Statistics

Baird Medical Investment has 35.73M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	35.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	2,108
FTD / Avg. Volume	1.15%

Short Selling Information

The latest short interest is 64.13K, so 0.17% of the outstanding shares have been sold short.

Short Interest	64.13K
Short % of Shares Out	0.17%
Short % of Float	0.47%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 15.6 and the forward PE ratio is null. Baird Medical Investment's PEG ratio is -0.05.

PE Ratio	15.6
Forward PE	n/a
PS Ratio	5.24
Forward PS	n/a
PB Ratio	4.9
P/FCF Ratio	-21.19
PEG Ratio	-0.05

Financial Ratio History

Enterprise Valuation

Baird Medical Investment has an Enterprise Value (EV) of 212.13M.

EV / Sales	5.73
EV / EBITDA	13.12
EV / EBIT	-33.6
EV / FCF	-23.14

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.53.

Current Ratio	1.77
Quick Ratio	1.74
Debt / Equity	0.53
Debt / EBITDA	1.29
Debt / FCF	-2.28
Interest Coverage	26.55

Financial Efficiency

Return on Equity is 31.4% and Return on Invested Capital is 22.59%.

Return on Equity	31.4%
Return on Assets	15.97%
Return on Invested Capital	22.59%
Revenue Per Employee	$250.25K
Profits Per Employee	$84.14K
Employee Count	148
Asset Turnover	0.48
Inventory Turnover	3.38

Taxes

Income Tax	1.49M
Effective Tax Rate	10.57%

Stock Price Statistics

The stock price has increased by -79.84% in the last 52 weeks. The beta is -1, so Baird Medical Investment's price volatility has been lower than the market average.

Beta	-1
52-Week Price Change	-79.84%
50-Day Moving Average	3.74
200-Day Moving Average	4.43
Relative Strength Index (RSI)	37.62
Average Volume (20 Days)	182,896

Income Statement

In the last 12 months, Baird Medical Investment had revenue of 37.04M and earned 12.45M in profits. Earnings per share was 0.49.

Revenue	37.04M
Gross Profit	32.65M
Operating Income	15.32M
Net Income	12.45M
EBITDA	16.17M
EBIT	14.66M
Earnings Per Share (EPS)	0.49

Full Income Statement

Balance Sheet

The company has 2.97M in cash and 20.88M in debt, giving a net cash position of -17.91M.

Cash & Cash Equivalents	2.97M
Total Debt	20.88M
Net Cash	-17.91M
Retained Earnings	26.76M
Total Assets	77.96M
Working Capital	26.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.31M and capital expenditures -2.85M, giving a free cash flow of -9.17M.

Operating Cash Flow	-6.31M
Capital Expenditures	-2.85M
Free Cash Flow	-9.17M
FCF Per Share	-0.36

Full Cash Flow Statement

Margins

Gross margin is 88.16%, with operating and profit margins of 41.35% and 33.62%.

Gross Margin	88.16%
Operating Margin	41.35%
Pretax Margin	38.04%
Profit Margin	33.62%
EBITDA Margin	43.66%
EBIT Margin	41.35%
FCF Margin	-24.75%

Dividends & Yields

BDMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	6.41%
FCF Yield	-4.72%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for BDMD.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$2.45
Lynch Upside	9.87%
Graham Number	4.13
Graham Upside	85.2%

Scores

Altman Z-Score	3.27
Piotroski F-Score	5